199 related articles for article (PubMed ID: 16625028)
21. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
Keall PJ; Webb S
Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
[TBL] [Abstract][Full Text] [Related]
22. From cell population models to tumor control probability: including cell cycle effects.
Hillen T; de Vries G; Gong J; Finlay C
Acta Oncol; 2010 Nov; 49(8):1315-23. PubMed ID: 20843174
[TBL] [Abstract][Full Text] [Related]
23. Evidence of extranuclear cell sensitivity to alpha-particle radiation using a microdosimetric model. I. Presentation and validation of a microdosimetric model.
Chouin N; Bernardeau K; Davodeau F; Chérel M; Faivre-Chauvet A; Bourgeois M; Apostolidis C; Morgenstern A; Lisbona A; Bardiès M
Radiat Res; 2009 Jun; 171(6):657-63. PubMed ID: 19580472
[TBL] [Abstract][Full Text] [Related]
24. The influence of dose heterogeneity on tumour control probability in fractionated radiation therapy.
Wiklund K; Toma-Dasu I; Lind BK
Phys Med Biol; 2011 Dec; 56(23):7585-600. PubMed ID: 22086189
[TBL] [Abstract][Full Text] [Related]
25. The distribution of the number of alpha hits per target cell: a new parameter to improve risk assessment for cancer induction using ICRP models.
Fritsch P
Radiat Prot Dosimetry; 2007; 127(1-4):46-9. PubMed ID: 18227074
[TBL] [Abstract][Full Text] [Related]
26. Cell-cycle times and the tumour control probability.
Maler A; Lutscher F
Math Med Biol; 2010 Dec; 27(4):313-42. PubMed ID: 19966342
[TBL] [Abstract][Full Text] [Related]
27. Alpha-hit, cellular dose, cell transformation and inactivation probability distributions of radon progenies in the bronchial epithelium.
Szoke I; Balásházy I; Farkas A; Hofmann W; Szoke R; Fakir H; Kis E
Radiat Prot Dosimetry; 2006; 122(1-4):540-2. PubMed ID: 17145731
[TBL] [Abstract][Full Text] [Related]
28. Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.
Carlsson J; Eriksson V; Stenerlöw B; Lundqvist H
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1185-95. PubMed ID: 16718515
[TBL] [Abstract][Full Text] [Related]
29. Values of "S," , and <(z1)2> for dosimetry using alpha-particle emitters.
Stinchcomb TG; Roeske JC
Med Phys; 1999 Sep; 26(9):1960-71. PubMed ID: 10505886
[TBL] [Abstract][Full Text] [Related]
30. Evidence of extranuclear cell sensitivity to alpha-particle radiation using a microdosimetric model. II. Application of the microdosimetric model to experimental results.
Chouin N; Bernardeau K; Bardiès M; Faivre-Chauvet A; Bourgeois M; Apostolidis C; Morgenstern A; Lisbona A; Chérel M; Davodeau F
Radiat Res; 2009 Jun; 171(6):664-73. PubMed ID: 19580473
[TBL] [Abstract][Full Text] [Related]
31. EUCLID: an outcome analysis tool for high-dimensional clinical studies.
Gayou O; Parda DS; Miften M
Phys Med Biol; 2007 Mar; 52(6):1705-19. PubMed ID: 17327657
[TBL] [Abstract][Full Text] [Related]
32. On the surviving fraction in irradiated multicellular tumour spheroids: calculation of overall radiosensitivity parameters, influence of hypoxia and volume effects.
Horas JA; Olguin OR; Rizzotto MG
Phys Med Biol; 2005 Apr; 50(8):1689-701. PubMed ID: 15815090
[TBL] [Abstract][Full Text] [Related]
33. In vitro exposure of mammalian cells to radon: dosimetric considerations.
Jostes RF; Hui TE; James AC; Cross FT; Schwartz JL; Rotmensch J; Atcher RW; Evans HH; Mencl J; Bakale G
Radiat Res; 1991 Aug; 127(2):211-9. PubMed ID: 1947006
[TBL] [Abstract][Full Text] [Related]
34. A (238)Pu irradiator for exposure of cultured cells with alpha-radiation: construction, calibration and dosimetry.
Tisnek N; Kalanxhi E; Serkland CW; Iversen J; Belyakov OV; Dahle J
Appl Radiat Isot; 2009 Nov; 67(11):1998-2002. PubMed ID: 19716308
[TBL] [Abstract][Full Text] [Related]
35. Analysis of survival of C-18 cells after irradiation in suspension with chelated and ionic bismuth-212 using microdosimetry.
Stinchcomb TG; Roeske JC
Radiat Res; 1994 Oct; 140(1):48-54. PubMed ID: 7938454
[TBL] [Abstract][Full Text] [Related]
36. Radioimmunotherapy with alpha-particle emitters: microdosimetry of cells with a heterogeneous antigen expression and with various diameters of cells and nuclei.
Kvinnsland Y; Stokke T; Aurlien E
Radiat Res; 2001 Feb; 155(2):288-96. PubMed ID: 11175663
[TBL] [Abstract][Full Text] [Related]
37. Treatment of solid tumors by interstitial release of recoiling short-lived alpha emitters.
Arazi L; Cooks T; Schmidt M; Keisari Y; Kelson I
Phys Med Biol; 2007 Aug; 52(16):5025-42. PubMed ID: 17671351
[TBL] [Abstract][Full Text] [Related]
38. Stochastic aspects of primary cellular consequences of radon inhalation.
Szoke I; Farkas A; Balásházy I; Hofmann W
Radiat Res; 2009 Jan; 171(1):96-106. PubMed ID: 19138049
[TBL] [Abstract][Full Text] [Related]
39. The use of microdosimetric moments in evaluating cell survival for therapeutic alpha-particle emitters.
Roeske JC; Stinchcomb TG
Radiat Res; 1999 Jan; 151(1):31-8. PubMed ID: 9973081
[TBL] [Abstract][Full Text] [Related]
40. Alpha-particle microdosimetry.
Chouin N; Bardies M
Curr Radiopharm; 2011 Jul; 4(3):266-80. PubMed ID: 22201713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
